SlideShare une entreprise Scribd logo
1  sur  47
Télécharger pour lire hors ligne
PRESENTER : DR.ADITI
3D YEAR RESIDENT
MD ANAESTHESIA
GGSMCH
⦁ Closed circuit anaesthesia with carbon dioxide
absorption was used as early as 1850 by John Snow.
Because of the high costs and limited availability of
anaesthetic agents, early investigators frequently used
closed circuit techniques.
⦁ Brian Sword first described the circle breathing system
and delivery of closed circuit anaesthesia in 1930 . Lack
of efficient vaporizers along with poor understanding of
the pharmacokinetics of the newly developed halothane
led to the resurgence of high flow techniques.
DR.Aditi
Contd..
DR.Aditi
⦁ Low flow, partial rebreathing anaesthetic
techniques were first described by Foldes and
colleagues in 1952 which involved fresh gas
flows of 1 l/min.
⦁ Virtue, in 1974, reduced gas flows even further
in his minimal flow anaesthesia technique 500
ml/min.
Low flow anaesthesia has various definitions.
 Any technique that utilizes a fresh gas flow (FGF)
that is less than the alveolar ventilation can be
classified as Low flow anaesthesia.
 It can also be defined as a technique wherein at
least 50% of the expired gases had been returned
to the lungs after carbon dioxide absorption. This
would be satisfied when the FGF is less than about
two litres per minute.
DR.Aditi
According to Dorsch :
DR.Aditi
⦁ Low-flow anesthesia has been variously defined
as an inhalation technique in which a circle
system with absorbent is used with a fresh gas
inflow of
⦁ Less than the patient's alveolar minute
volume,
⦁ less than 4 L/minute
⦁ 3 L/minute or less
⦁ 0.5 to 2 L/minute
⦁ less than 1 or 1.5 L/minute or
⦁ 0.5 to 1 L/minute or 500 mL/minute
Baker classified the FGF used in anaesthetic practice
into :
1. Medium flow : 1 - 2 l/min.
2. Low flow : 500- 1000 ml/min.
3. Minimal flow : 250-500 ml/min.
4. Metabolic flow : about 250 ml /min
For most practical considerations, utilisation of a
fresh gas flow less than 2 litres/min may be
considered as low flow anaesthesia.
DR.Aditi
⦁ Completely closed circuit anaesthesia is based upon the
reasoning that anaesthesia can be safely be maintained ,if
the gases which are taken up by the body alone are
replaced into the circuit. Taking care to remove the expired
carbon dioxide with soda lime.
⦁ No gas escapes out of the circuit and would provide for
maximal efficiency for the utilisation of the fresh gas flow.
⦁ The very nature of this system requires that the exact
amount of anaesthetic agent taken up by the body be
known, since that exact amount has to be added into the
circuit. DR.Aditi
Contd…
DR.Aditi
⦁ Any error in this could lead to potentially
dangerous level of anaesthetic agent be present
in the inspired mixture with its attended
complications. So we have to be cautious while
using low flow anaesthesia.
1. Circle rebreathing system with CO2 absorption
2.Accurate flow meters for adjustments of FGF below
1L/min
3.Gas tight breathing system. Recommended test
leakage should be below 150 mL/min at 30 cm H2 O
test pressure.
DR.Aditi
CO NTD ..
DR.Aditi
5. The breathing system should have minimal internal
volume and a minimum number of components and
connections.
6.Continuous gas monitoring MUST be employed. From
the clinical standpoint the measurement of expiratory
gas concentrations close to the Y-piece is of crucial
importance. That information is essential in controlling
the patient’s alveolar gas concentrations, whereas Fi
reflect the adequacy of gas concentrations into the
breathing circuit.
Contd..
DR.Aditi
⦁ 7.VAPOURIZERS :
 Calibrated vaporizers - Vaporizers capable of
delivering high concentrations and that are
accurate at low fresh gas flows are required.
 Liquid injection - Anesthetic liquid can be
injected directly into the expiratory limb
 In circle vaporizer - In-system vaporizers
have been used successfully with both
spontaneous and controlled ventilation
DR.Aditi
Monitoring
 Inspired O2 concentration should be monitored at
all times if N2O is used in more than 65%
concentration, as one of the adjuvant gas.
 EtCO2 monitoring seems to be necessary to ensure
proper functioning of the absorber.
 If monitoring of end tidal anaesthetic
concentration is available, the administration of
low flow anaesthesia becomes very easy.
DR.Aditi
DR.Aditi
HOW TO ADJUST FGF AT DIFFERENT
PHASES OF LFA
DR.Aditi
Premedication, pre-oxygenation and induction of
sleep are performed according to the usual practice.
Concerning adjustment of FGF anesthesia can be
divided into 3 phases:
1. Initial HIGH flow
2. Low flow
3. Recovery
1.Initial HIGH flow phase
⦁ Primary aim at the start of low flow anaesthesia is
to achieve an alveolar concentration of the
anaesthetic agent that is adequate for producing
surgical anaesthesia.
⦁ The factors that can influence the build up of
alveolar concentration should all be considered
while trying to reach the desired alveolar
concentration. (MAC)
🞂
DR.Aditi
DR.Aditi
• Use of high flows for a short time
• Prefilled circuit
• Use of large doses of anaesthetic agents.
Injection techniques :The exact dose to be used is
calculated thus:
Priming dose (ml vapour) = Desired concentration x {(
FRC + Circuit volume)
+( Cardiac output x B G Coeff.)}
DR.Aditi
 An alternative method for administering the large
amounts of the agents is by directly injecting the agent
into the circuit.
 This is an old, time-tested method and is extremely
reliable. Each ml of the liquid halothane, on vaporisation
yields 226 ml of vapour and each ml of liquid isoflurane
yields 196 ml of vapour at 20oC.
 Hence, the requirement of about 2ml of the agent is
injected in small increments into the circuit. The high
volatility coupled with the high temperature in the circle
results in instantaneous vaporisation of the agent.
DR.Aditi
DR.Aditi
 The intermittent injections are often made in 0.2-
DR.Aditi
0.5 ml aliquots manually.
 Doses should never exceed 1ml at a time. Doses
exceeding 2 ml bolus invite disaster.
 Intermittent injections can often be easily
substituted with a continuous infusion with the
added advantage of doing away with the peaks and
troughs associated with intermittent injections.
DR.Aditi
 This priming dose is the dose required to bring the
circuit volume + FRC to the desired concentration
and is injected over the first few minutes of the
closed circuit anaesthesia.
 Besides this, an amount of agent necessary to
compensate for the uptake of the body must also
be added and this is calculated depending on the
uptake model being used.
DR.Aditi
2. Low flow phase
DR.Aditi
After the high flow phase of 5-15 min, or when the
target gas concentrations has been achieved FGF can
be reduced at the desired low flow level.
The lower the FGF the greater the difference between the
vaporizer setting and inspired concentration of the
anesthetic agent in the breathing circuit will be.
With low FGF, time to reach the desired concentration in
the inspiratory gas will be prolonged.
Hence, monitoring of oxygen and anesthetic agent
concentration is essential and necessary in LFA.
⦁ If the flow provided is too small for the patient’s
needs the bellow will gradually go down, down
down...
DR.Aditi
THE MAINTENANCE OF LOW FLOW
ANAESTHESIA
DR.Aditi
⦁ This phase is characterised by
1.Need for a steady state anaesthesia often
meaning a steady alveolar concentration of
respiratory gases.
2.Minimal uptake of the anaesthetic agents
by the body.
3. Need to prevent hypoxic gas mixtures.
⦁ A high flow of 10 lit/min at the start, for a period of
3 minutes, is followed by a flow of 400 ml of O2 and
600 ml of N2O for the initial 20 minutes.
⦁ And a flow of 500 ml of O2 and 500 ml of N2O
thereafter.
⦁ This has been shown to maintain the oxygen
concentration between 33 and 40 % at all times.
DR.Aditi
Management of the oxygen and nitrous
oxide flow during the maintenance
phase
Constant circuit volume :
DR.Aditi
 Constant reservoir bag size : if the bag decreases in size.
The fresh gas flow rate is increased. If the bag increases in
size, the flow is decreased.
 Ventilator with Ascending bellows: constant volume can be
achieved by adjusting the fresh gas flow so that bellows is
below the top of its housing at the end of exhalation.
 Ventilator with Descending bellows: the fresh gas flow so
that bellows just reaches the bottom of its housing at the
end of exhalation.
Important Equations :
DR.Aditi
⦁ VO2 = 10 × BW KG ^ ¾ BRODY EQUATION
⦁ V N20 = 1000 × t ^ ½
EQUATION
SEVERINGHAUS
⦁ V AN = desired concentration × λB/G × Q × t − 1/2
LOWE EQUATION
⦁ Time constant :
⦁ The time constant is a measure for the time it takes,
that alterations of the fresh gas composition will lead to
corresponding alterations of the gas composition within
the breathing system. According to a formula given by
Conway the time constant (T) can be calculated by the
division of the system's volume (VS) by the difference
between the amount of anaesthetic agent delivered into
the system with the fresh gas (VD) and the individual
gas uptake (VU):
⦁ T = VS / (VD - VU)
DR.Aditi
 The Gothenburg Technique :
 Initially high flows, oxygen at 1.5 l/min and nitrous
oxide at 3.5 l/min had to be used for a period of six
minutes after the induction of anaesthesia and this
constitutes the loading phase.
 This is followed by the maintenance phase in which the
oxygen flow is reduced to about 4ml/kg
 And nitrous oxide flow adjusted to maintain a constant
oxygen concentration in the circuit.
 The usual desired oxygen concentration is about 40%.
DR.Aditi
Management of the potent anaesthetic
agents during maintenance phase
DR.Aditi
Weir and Kennedy recommend infusion of halothane
(in liquid ml/hr) at the following rates
for a 50 kg adult at different time intervals.
0-5 min 27 ml/hr
5-30 min 5.71 ml/hr
30-60 min 3.33ml/hr
60-120 min 2.36 ml/hr
These infusion rates had been derived from the
Lowe's theory of the uptake of anaesthetic agent.
They had approximated isoflurane infusion (in liquid ml/hr)
based on the Lowe's formula as follows:
0 - 5 min. 14 + 0.4X wt. ml/hr.
5 - 30 min. 0.2 X initial rate.
30-60 min. 0.12Xinitial rate.
60-120min. 0.08X initial rate.
For halothane infusion, they had suggested that the above
said rates be multiplied by 0.8
And for enflurane, multiplied by 1.6. These rates had
been suggested to produce 1.3 MAC without the use of
nitrous oxide. The infusion rates had to be halved if nitrous
oxide is used.
DR.Aditi
Category
DR.Aditi
High flow
5L/Min
Inter
Mediate 2.5
l/min
Low flow 1
l/min
Minimal
Flow 0.5
l/min
Closed
circuit 0.3 –
0.5 l/min
Percentage 0 %
rebreathing
52% 86% 97% 100%
Circuit
concentratio
n with
vaporizer set
to 1% (at 1
h)
1 % 0.94% 0.68% 0.54% N2O 0.52%
NO N2O
0.39 %
Vaporizer
setting for in
inspired
concentratio
n of 1% ( at
1 h)
1% 1.1% 1.4% 2.0% N2O 2.4%
NO N20
3.2%
Low flow with Dräger machine :
DR.Aditi
⦁ With the connection of the patient to the anaesthesia
machine, an initial phase of high fresh gas flow (4-6
L/min) follows. During this initial phase, adequate
denitrogenation and distribution of anaesthetic gases in
the desired concentration throughout the system is
achieved and the desired level of anaesthesia is attained.
⦁ The duration of the initial phase is determined by the
amount of flow reduction and the individual gas uptake
(4-5 L/min, 6-8 min).
⦁ After this time, oxygen and nitrous oxide levels reach 30% O2 and
65% N2 O, respectively . If isoflurane is used, the vaporizer is set to
1.5%; enflurane and sevoflurane require 2.5% setting and desflurane
requires a 4-6% setting.
⦁ After 6-8 min, an expiratory concentration corresponding to 0.8
MAC of the respective anaesthetic agent is attained. At an additive
nitrous oxide concentration of 50-60%, this value approximately
corresponds to AD95, or agent concentration at which 95% of
patients tolerate a skin incision without noticeable reaction.
⦁ After 10 min, the total gas uptake of an adult patient is about 600
ml/min, so that at this time, the flow can be reduced to 1.0 L/min
and low flow anaesthesia can be initiated.
DR.Aditi
⦁ An inspiratory oxygen concentration level of 30% can only be
maintained if the fresh gas oxygen concentration is increased to
50% once the flow has been reduced.
⦁ Flow reduction also decreases the amount of anaesthetic agent,
which is introduced into the fresh gas flow by the vaporizer.
⦁ If the initially selected anaesthetic agent concentration of 0.8 ×
MAC is to be maintained, the vaporizer must be adjusted for 3.0%.
⦁ For desflurane, no changes are necessary.
⦁ Before reducing fresh gas flow rates to even lower levels, i.e., 0.5
L/min, to perform minimal flow anaesthesia, the initial phase
should be extended to 15 min and for very large patients to 20
min. DR.Aditi
DR.Aditi
⦁ Because the rebreathing fraction is increased
compared with low flow anaesthesia, oxygen
concentration should be increased to 60%; 50%
represents an absolute minimum value.
⦁ An expiratory anaesthetic agent concentration of 0.8 ×
MAC should be maintained with appropriate dial
setting.
⦁ In low flow anaesthesia, the composition of anaesthetic
gases changes continuously during the course of
anaesthesia, making intermittent adjustments to fresh
gas composition necessary.
DR.Aditi
Precautions :
DR.Aditi
⦁ If a rapid change in any component of inspired
mixture is desired, FGF should be increased.
⦁ If integrity of circle is broken high flows should be
used for several minutes before returning to low flow.
⦁ If closed anaesthesia system is used its
recommended that high flow be used for 1-2 minutes
every hour to eliminate gases such as nitrogen and
carbon monoxide.
3. Emergence phase
DR.Aditi
At the end of anesthesia high FGF, usually 100%
O2, is necessary, to facilitate the washout of the
anesthetic agent from the patient and to remove the
agent to the scavenging system.
A charcoal filter can be placed in expiratory limb. It
will cause a rapid decrease in volatile agent
concentration.
There are only two recognised methods of termination
of the closed circuit. They are as follows:
1 )Towards the end of the anaesthesia, the circuit is
opened and a high flow of gas is used to flush out
the anaesthetic agents which accelerates the
washout of the anaesthetic agents.
This has the obvious advantage of simplicity but
would result in wastage of gases.
2 )The second method is the use of activated
charcoal. Activated charcoal when heated to 220oC
adsorbs the potent vapours almost completely.
DR.Aditi
Advantage :
DR.Aditi
 Economic Benefits
 Reduce Operating Room Pollution
 Environmental Benefits
 Estimation Of Anesthetic Agent Uptake And Oxygen
Consumption
 Buffered Changes In Inspired Conc.
 Heat And Humidity Conservation
 Less Danger Of Barotrauma
 Quality Of Patient Care
Disadvantage :
DR.Aditi
More Attention Required
Inability to Quickly Alter Inspired Concentrations
Danger of Hypercarbia
Accumulation of Undesirable Gases in the
System(CO, Methane, Acetone, Hydrogen, Ethanol,
Compound A, Argon, Nitrogen)
Uncertainty about Inspired Concentrations
Faster Absorbent Exhaustion
DR.Aditi
⦁ Many new anesthesia machines have been
developed in Europe within the past few years.
One of these is the Physioflex machine .
Another is Drager Zeus.
⦁ These machines have an inbuilt algorithm to
calculate the uptake and adjust concentration
and volume accordingly.
DR.Aditi
DR.Aditi

Contenu connexe

Tendances

Flowmeter colour bobbins
Flowmeter colour bobbinsFlowmeter colour bobbins
Flowmeter colour bobbinsRmdsrk
 
scavenging system and hazards
scavenging system and hazardsscavenging system and hazards
scavenging system and hazardsGowri Shankar
 
anaesthesia Breathing circuits and its classification and functional analysis
anaesthesia Breathing circuits and its classification and functional analysisanaesthesia Breathing circuits and its classification and functional analysis
anaesthesia Breathing circuits and its classification and functional analysisprateek gupta
 
Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction Arun Shetty
 
SAFETY FEATURES OF ANAESTHESIA MACHINE
SAFETY FEATURES OF ANAESTHESIA MACHINESAFETY FEATURES OF ANAESTHESIA MACHINE
SAFETY FEATURES OF ANAESTHESIA MACHINEMAHESWARI JAIKUMAR
 
Oxygen MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECT
Oxygen  MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECTOxygen  MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECT
Oxygen MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECTDr.RMLIMS lucknow
 
Occupational hazards of Anesthesia
Occupational hazards of AnesthesiaOccupational hazards of Anesthesia
Occupational hazards of AnesthesiaSonu Kashyap
 
NEUROMUSCULAR MONITORING
NEUROMUSCULAR MONITORINGNEUROMUSCULAR MONITORING
NEUROMUSCULAR MONITORINGAshish Gupta
 
Low pressure system in anaesthesia machine
Low pressure system in anaesthesia machineLow pressure system in anaesthesia machine
Low pressure system in anaesthesia machineSwadheen Rout
 
Anaesthesia breathing systems
Anaesthesia breathing systemsAnaesthesia breathing systems
Anaesthesia breathing systemsZIKRULLAH MALLICK
 
Bronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubesBronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubesDhritiman Chakrabarti
 
Copd and anaesthetic management
Copd and anaesthetic managementCopd and anaesthetic management
Copd and anaesthetic managementKanika Chaudhary
 

Tendances (20)

Vaporizers
Vaporizers Vaporizers
Vaporizers
 
Flowmeter colour bobbins
Flowmeter colour bobbinsFlowmeter colour bobbins
Flowmeter colour bobbins
 
Lfa
LfaLfa
Lfa
 
scavenging system and hazards
scavenging system and hazardsscavenging system and hazards
scavenging system and hazards
 
anaesthesia Breathing circuits and its classification and functional analysis
anaesthesia Breathing circuits and its classification and functional analysisanaesthesia Breathing circuits and its classification and functional analysis
anaesthesia Breathing circuits and its classification and functional analysis
 
Anesthesia machine
Anesthesia machineAnesthesia machine
Anesthesia machine
 
Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction Intro to Hypoxic pulmonary vasoconstriction
Intro to Hypoxic pulmonary vasoconstriction
 
SAFETY FEATURES OF ANAESTHESIA MACHINE
SAFETY FEATURES OF ANAESTHESIA MACHINESAFETY FEATURES OF ANAESTHESIA MACHINE
SAFETY FEATURES OF ANAESTHESIA MACHINE
 
Oxygen MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECT
Oxygen  MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECTOxygen  MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECT
Oxygen MANUFACTRE STORAGE PREPERATION AND CLINICAL ASPECT
 
Anaesthesia machine 2
Anaesthesia machine 2Anaesthesia machine 2
Anaesthesia machine 2
 
Occupational hazards of Anesthesia
Occupational hazards of AnesthesiaOccupational hazards of Anesthesia
Occupational hazards of Anesthesia
 
Low flow anaesthesia
Low flow anaesthesiaLow flow anaesthesia
Low flow anaesthesia
 
NEUROMUSCULAR MONITORING
NEUROMUSCULAR MONITORINGNEUROMUSCULAR MONITORING
NEUROMUSCULAR MONITORING
 
Low pressure system in anaesthesia machine
Low pressure system in anaesthesia machineLow pressure system in anaesthesia machine
Low pressure system in anaesthesia machine
 
Anaesthesia breathing systems
Anaesthesia breathing systemsAnaesthesia breathing systems
Anaesthesia breathing systems
 
Awake intubation distribution
Awake intubation distributionAwake intubation distribution
Awake intubation distribution
 
Bronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubesBronchial blockers & endobronchial tubes
Bronchial blockers & endobronchial tubes
 
Copd and anaesthetic management
Copd and anaesthetic managementCopd and anaesthetic management
Copd and anaesthetic management
 
The canister (the absorber)
The canister (the absorber)The canister (the absorber)
The canister (the absorber)
 
Anaesthesia workstation
Anaesthesia workstationAnaesthesia workstation
Anaesthesia workstation
 

Similaire à lfa-161006111615.pptx

Inahalational Anaesthesia
Inahalational AnaesthesiaInahalational Anaesthesia
Inahalational AnaesthesiaAshwin Haridas
 
Oxygen therapy principles_and_practice shahna ali
Oxygen therapy principles_and_practice shahna ali Oxygen therapy principles_and_practice shahna ali
Oxygen therapy principles_and_practice shahna ali Shahnaali
 
lowflowsystem-200601004249.pptx
lowflowsystem-200601004249.pptxlowflowsystem-200601004249.pptx
lowflowsystem-200601004249.pptxJaseerAk1
 
Ppt on oxygen administration
Ppt on oxygen administrationPpt on oxygen administration
Ppt on oxygen administrationsuchitrarati
 
Spotters , exam purposes, instruments for critical care medicine , pulmonary ...
Spotters , exam purposes, instruments for critical care medicine , pulmonary ...Spotters , exam purposes, instruments for critical care medicine , pulmonary ...
Spotters , exam purposes, instruments for critical care medicine , pulmonary ...DrAmbikaGupta
 
5. Oxygen Therapy.pptx
5. Oxygen Therapy.pptx5. Oxygen Therapy.pptx
5. Oxygen Therapy.pptxAme Mehadi
 
Anesthesia machine
Anesthesia machine Anesthesia machine
Anesthesia machine dtgvyukj
 
oxygen delivery devices 1.pptx
oxygen delivery devices 1.pptxoxygen delivery devices 1.pptx
oxygen delivery devices 1.pptxsanikashukla2
 
Oxygen therapy equipment
Oxygen therapy equipment Oxygen therapy equipment
Oxygen therapy equipment Moh Basyouni
 
oxygen therapy and toxicity
oxygen therapy and toxicityoxygen therapy and toxicity
oxygen therapy and toxicityRaghavendra Babu
 
Seminar Presentation on Oxygen Administration.pptx
Seminar Presentation on Oxygen Administration.pptxSeminar Presentation on Oxygen Administration.pptx
Seminar Presentation on Oxygen Administration.pptxRebiraWorkineh
 
Oxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptx
Oxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptxOxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptx
Oxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptxRitesh Pandey
 

Similaire à lfa-161006111615.pptx (20)

Inahalational Anaesthesia
Inahalational AnaesthesiaInahalational Anaesthesia
Inahalational Anaesthesia
 
Oxygen therapy principles_and_practice shahna ali
Oxygen therapy principles_and_practice shahna ali Oxygen therapy principles_and_practice shahna ali
Oxygen therapy principles_and_practice shahna ali
 
0xygen therapy
0xygen therapy0xygen therapy
0xygen therapy
 
lowflowsystem-200601004249.pptx
lowflowsystem-200601004249.pptxlowflowsystem-200601004249.pptx
lowflowsystem-200601004249.pptx
 
Ppt on oxygen administration
Ppt on oxygen administrationPpt on oxygen administration
Ppt on oxygen administration
 
Spotters , exam purposes, instruments for critical care medicine , pulmonary ...
Spotters , exam purposes, instruments for critical care medicine , pulmonary ...Spotters , exam purposes, instruments for critical care medicine , pulmonary ...
Spotters , exam purposes, instruments for critical care medicine , pulmonary ...
 
Oxygen therapy
Oxygen therapyOxygen therapy
Oxygen therapy
 
Oxygen therapy
Oxygen therapyOxygen therapy
Oxygen therapy
 
Oxygen therapy
Oxygen therapyOxygen therapy
Oxygen therapy
 
5. Oxygen Therapy.pptx
5. Oxygen Therapy.pptx5. Oxygen Therapy.pptx
5. Oxygen Therapy.pptx
 
Anesthesia machine
Anesthesia machine Anesthesia machine
Anesthesia machine
 
oxygen delivery devices 1.pptx
oxygen delivery devices 1.pptxoxygen delivery devices 1.pptx
oxygen delivery devices 1.pptx
 
Oxygen therapy
Oxygen therapyOxygen therapy
Oxygen therapy
 
Oxygen therapy
Oxygen therapy Oxygen therapy
Oxygen therapy
 
Oxygen therapy equipment
Oxygen therapy equipment Oxygen therapy equipment
Oxygen therapy equipment
 
oxygen therapy and toxicity
oxygen therapy and toxicityoxygen therapy and toxicity
oxygen therapy and toxicity
 
Seminar Presentation on Oxygen Administration.pptx
Seminar Presentation on Oxygen Administration.pptxSeminar Presentation on Oxygen Administration.pptx
Seminar Presentation on Oxygen Administration.pptx
 
Oxygen therapy final
Oxygen therapy  finalOxygen therapy  final
Oxygen therapy final
 
Oxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptx
Oxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptxOxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptx
Oxygenation – Peri intubation, Apnoeic, THRIVE - Copy.pptx
 
Oxygen delivery systems
Oxygen delivery systemsOxygen delivery systems
Oxygen delivery systems
 

Plus de MarkJohnson895316

cooooppppd.pptx acute exacerbation of asthma
cooooppppd.pptx acute exacerbation of asthmacooooppppd.pptx acute exacerbation of asthma
cooooppppd.pptx acute exacerbation of asthmaMarkJohnson895316
 
ketki asthma.pptx HDU/ICU care HDU/ICU care
ketki asthma.pptx HDU/ICU care HDU/ICU careketki asthma.pptx HDU/ICU care HDU/ICU care
ketki asthma.pptx HDU/ICU care HDU/ICU careMarkJohnson895316
 
8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA
8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA
8009885.ppt BASIC LIFE SUPPORT ANAESTHESIAMarkJohnson895316
 
CPR CARDIO PULMONARY RESUSTICATION ANAESTHESIA
CPR CARDIO PULMONARY RESUSTICATION ANAESTHESIACPR CARDIO PULMONARY RESUSTICATION ANAESTHESIA
CPR CARDIO PULMONARY RESUSTICATION ANAESTHESIAMarkJohnson895316
 
local_anaesthesia-pharmacology2.ppt
local_anaesthesia-pharmacology2.pptlocal_anaesthesia-pharmacology2.ppt
local_anaesthesia-pharmacology2.pptMarkJohnson895316
 
Advancement in Supra-glottic Airways.ppt
Advancement in Supra-glottic Airways.pptAdvancement in Supra-glottic Airways.ppt
Advancement in Supra-glottic Airways.pptMarkJohnson895316
 
postoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptx
postoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptxpostoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptx
postoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptxMarkJohnson895316
 
32588_P0ST-OPERATIVE CARE.ppt
32588_P0ST-OPERATIVE CARE.ppt32588_P0ST-OPERATIVE CARE.ppt
32588_P0ST-OPERATIVE CARE.pptMarkJohnson895316
 
bec-altered-mental-status.pptx
bec-altered-mental-status.pptxbec-altered-mental-status.pptx
bec-altered-mental-status.pptxMarkJohnson895316
 

Plus de MarkJohnson895316 (18)

cooooppppd.pptx acute exacerbation of asthma
cooooppppd.pptx acute exacerbation of asthmacooooppppd.pptx acute exacerbation of asthma
cooooppppd.pptx acute exacerbation of asthma
 
ketki asthma.pptx HDU/ICU care HDU/ICU care
ketki asthma.pptx HDU/ICU care HDU/ICU careketki asthma.pptx HDU/ICU care HDU/ICU care
ketki asthma.pptx HDU/ICU care HDU/ICU care
 
8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA
8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA
8009885.ppt BASIC LIFE SUPPORT ANAESTHESIA
 
CPR CARDIO PULMONARY RESUSTICATION ANAESTHESIA
CPR CARDIO PULMONARY RESUSTICATION ANAESTHESIACPR CARDIO PULMONARY RESUSTICATION ANAESTHESIA
CPR CARDIO PULMONARY RESUSTICATION ANAESTHESIA
 
local_anaesthesia-pharmacology2.ppt
local_anaesthesia-pharmacology2.pptlocal_anaesthesia-pharmacology2.ppt
local_anaesthesia-pharmacology2.ppt
 
sa090418.pptx
sa090418.pptxsa090418.pptx
sa090418.pptx
 
Advancement in Supra-glottic Airways.ppt
Advancement in Supra-glottic Airways.pptAdvancement in Supra-glottic Airways.ppt
Advancement in Supra-glottic Airways.ppt
 
5710005.ppt
5710005.ppt5710005.ppt
5710005.ppt
 
blood-PPT.pptx
blood-PPT.pptxblood-PPT.pptx
blood-PPT.pptx
 
blood_products.ppt
blood_products.pptblood_products.ppt
blood_products.ppt
 
postoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptx
postoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptxpostoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptx
postoperativecarepleasedontdeleteplease-130129233843-phpapp02.pptx
 
32588_P0ST-OPERATIVE CARE.ppt
32588_P0ST-OPERATIVE CARE.ppt32588_P0ST-OPERATIVE CARE.ppt
32588_P0ST-OPERATIVE CARE.ppt
 
clostridium perfringens.ppt
clostridium perfringens.pptclostridium perfringens.ppt
clostridium perfringens.ppt
 
BREATHING SYSTEMS 1.pptx
BREATHING SYSTEMS 1.pptxBREATHING SYSTEMS 1.pptx
BREATHING SYSTEMS 1.pptx
 
5063905.ppt
5063905.ppt5063905.ppt
5063905.ppt
 
3722183.ppt
3722183.ppt3722183.ppt
3722183.ppt
 
10420271.ppt
10420271.ppt10420271.ppt
10420271.ppt
 
bec-altered-mental-status.pptx
bec-altered-mental-status.pptxbec-altered-mental-status.pptx
bec-altered-mental-status.pptx
 

Dernier

Subconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptxSubconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptxvideosfildr
 
AMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxAMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxDileepRedemption
 
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEMLABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEMRommel Luis III Israel
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalA-dec Australia
 
The Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptxThe Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptxBarshaBarsha6
 
Disseminated Intravascular Coagulation.ppt
Disseminated Intravascular Coagulation.pptDisseminated Intravascular Coagulation.ppt
Disseminated Intravascular Coagulation.pptSameer Jain
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...Compliatric Where Compliance Happens
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
arpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationarpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationNursing education
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationpratiksha ghimire
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionNeighborhood Trainer
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?HelenBevan4
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Medisep insurance policy , new kerala government insurance policy for govrnm...
Medisep insurance policy , new  kerala government insurance policy for govrnm...Medisep insurance policy , new  kerala government insurance policy for govrnm...
Medisep insurance policy , new kerala government insurance policy for govrnm...LinshaLichu1
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfAditiAlishetty
 
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE  STUDY ON CHRONIC KIDNEY DISEASE.pptxCASE  STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptxdrsriram2001
 
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxravisutar1
 
Family Adoption Programme first year mbbs.pptx
Family Adoption Programme first year mbbs.pptxFamily Adoption Programme first year mbbs.pptx
Family Adoption Programme first year mbbs.pptxKritikaMishra43
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translationHelenBevan4
 

Dernier (20)

Subconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptxSubconjunctival Haemorrhage,causes,treatment..pptx
Subconjunctival Haemorrhage,causes,treatment..pptx
 
AMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptxAMIKINHAL Presentation Journal Club (3).pptx
AMIKINHAL Presentation Journal Club (3).pptx
 
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEMLABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
LABORATORY PROCEDURES-ALTERATION IN THE ENDOCRINE SYSTEM
 
Discover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa DentalDiscover the Art Deco Style at Spa Dental
Discover the Art Deco Style at Spa Dental
 
The Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptxThe Best Diet for Preventing and Managing Kidney Stones .pptx
The Best Diet for Preventing and Managing Kidney Stones .pptx
 
Disseminated Intravascular Coagulation.ppt
Disseminated Intravascular Coagulation.pptDisseminated Intravascular Coagulation.ppt
Disseminated Intravascular Coagulation.ppt
 
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
2024 Compliatric Webinar Series - OSV Overview and Panel Discussion April 202...
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
arpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and educationarpita 1-1.pptx management of nursing service and education
arpita 1-1.pptx management of nursing service and education
 
Back care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentationBack care and back massage. powerpoint presentation
Back care and back massage. powerpoint presentation
 
Enhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized NutritionEnhancing Health Through Personalized Nutrition
Enhancing Health Through Personalized Nutrition
 
Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?Leading big change: what does it take to deliver at large scale?
Leading big change: what does it take to deliver at large scale?
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Medisep insurance policy , new kerala government insurance policy for govrnm...
Medisep insurance policy , new  kerala government insurance policy for govrnm...Medisep insurance policy , new  kerala government insurance policy for govrnm...
Medisep insurance policy , new kerala government insurance policy for govrnm...
 
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdfPreventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
Preventing Common Nutritional Deficiencies In Poultry Flocks (PPT).pdf
 
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE  STUDY ON CHRONIC KIDNEY DISEASE.pptxCASE  STUDY ON CHRONIC KIDNEY DISEASE.pptx
CASE STUDY ON CHRONIC KIDNEY DISEASE.pptx
 
Best Sharjah Spa Jameela Massage Center Sharjah
Best Sharjah Spa Jameela Massage Center SharjahBest Sharjah Spa Jameela Massage Center Sharjah
Best Sharjah Spa Jameela Massage Center Sharjah
 
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptxPresentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptx
 
Family Adoption Programme first year mbbs.pptx
Family Adoption Programme first year mbbs.pptxFamily Adoption Programme first year mbbs.pptx
Family Adoption Programme first year mbbs.pptx
 
The future of change - strategic translation
The future of change - strategic translationThe future of change - strategic translation
The future of change - strategic translation
 

lfa-161006111615.pptx

  • 1. PRESENTER : DR.ADITI 3D YEAR RESIDENT MD ANAESTHESIA GGSMCH
  • 2. ⦁ Closed circuit anaesthesia with carbon dioxide absorption was used as early as 1850 by John Snow. Because of the high costs and limited availability of anaesthetic agents, early investigators frequently used closed circuit techniques. ⦁ Brian Sword first described the circle breathing system and delivery of closed circuit anaesthesia in 1930 . Lack of efficient vaporizers along with poor understanding of the pharmacokinetics of the newly developed halothane led to the resurgence of high flow techniques. DR.Aditi
  • 3. Contd.. DR.Aditi ⦁ Low flow, partial rebreathing anaesthetic techniques were first described by Foldes and colleagues in 1952 which involved fresh gas flows of 1 l/min. ⦁ Virtue, in 1974, reduced gas flows even further in his minimal flow anaesthesia technique 500 ml/min.
  • 4. Low flow anaesthesia has various definitions.  Any technique that utilizes a fresh gas flow (FGF) that is less than the alveolar ventilation can be classified as Low flow anaesthesia.  It can also be defined as a technique wherein at least 50% of the expired gases had been returned to the lungs after carbon dioxide absorption. This would be satisfied when the FGF is less than about two litres per minute. DR.Aditi
  • 5. According to Dorsch : DR.Aditi ⦁ Low-flow anesthesia has been variously defined as an inhalation technique in which a circle system with absorbent is used with a fresh gas inflow of ⦁ Less than the patient's alveolar minute volume, ⦁ less than 4 L/minute ⦁ 3 L/minute or less ⦁ 0.5 to 2 L/minute ⦁ less than 1 or 1.5 L/minute or ⦁ 0.5 to 1 L/minute or 500 mL/minute
  • 6. Baker classified the FGF used in anaesthetic practice into : 1. Medium flow : 1 - 2 l/min. 2. Low flow : 500- 1000 ml/min. 3. Minimal flow : 250-500 ml/min. 4. Metabolic flow : about 250 ml /min For most practical considerations, utilisation of a fresh gas flow less than 2 litres/min may be considered as low flow anaesthesia. DR.Aditi
  • 7. ⦁ Completely closed circuit anaesthesia is based upon the reasoning that anaesthesia can be safely be maintained ,if the gases which are taken up by the body alone are replaced into the circuit. Taking care to remove the expired carbon dioxide with soda lime. ⦁ No gas escapes out of the circuit and would provide for maximal efficiency for the utilisation of the fresh gas flow. ⦁ The very nature of this system requires that the exact amount of anaesthetic agent taken up by the body be known, since that exact amount has to be added into the circuit. DR.Aditi
  • 8. Contd… DR.Aditi ⦁ Any error in this could lead to potentially dangerous level of anaesthetic agent be present in the inspired mixture with its attended complications. So we have to be cautious while using low flow anaesthesia.
  • 9. 1. Circle rebreathing system with CO2 absorption 2.Accurate flow meters for adjustments of FGF below 1L/min 3.Gas tight breathing system. Recommended test leakage should be below 150 mL/min at 30 cm H2 O test pressure. DR.Aditi
  • 10. CO NTD .. DR.Aditi 5. The breathing system should have minimal internal volume and a minimum number of components and connections. 6.Continuous gas monitoring MUST be employed. From the clinical standpoint the measurement of expiratory gas concentrations close to the Y-piece is of crucial importance. That information is essential in controlling the patient’s alveolar gas concentrations, whereas Fi reflect the adequacy of gas concentrations into the breathing circuit.
  • 11. Contd.. DR.Aditi ⦁ 7.VAPOURIZERS :  Calibrated vaporizers - Vaporizers capable of delivering high concentrations and that are accurate at low fresh gas flows are required.  Liquid injection - Anesthetic liquid can be injected directly into the expiratory limb  In circle vaporizer - In-system vaporizers have been used successfully with both spontaneous and controlled ventilation
  • 13. Monitoring  Inspired O2 concentration should be monitored at all times if N2O is used in more than 65% concentration, as one of the adjuvant gas.  EtCO2 monitoring seems to be necessary to ensure proper functioning of the absorber.  If monitoring of end tidal anaesthetic concentration is available, the administration of low flow anaesthesia becomes very easy. DR.Aditi
  • 15. HOW TO ADJUST FGF AT DIFFERENT PHASES OF LFA DR.Aditi Premedication, pre-oxygenation and induction of sleep are performed according to the usual practice. Concerning adjustment of FGF anesthesia can be divided into 3 phases: 1. Initial HIGH flow 2. Low flow 3. Recovery
  • 16. 1.Initial HIGH flow phase ⦁ Primary aim at the start of low flow anaesthesia is to achieve an alveolar concentration of the anaesthetic agent that is adequate for producing surgical anaesthesia. ⦁ The factors that can influence the build up of alveolar concentration should all be considered while trying to reach the desired alveolar concentration. (MAC) 🞂 DR.Aditi
  • 18. • Use of high flows for a short time • Prefilled circuit • Use of large doses of anaesthetic agents. Injection techniques :The exact dose to be used is calculated thus: Priming dose (ml vapour) = Desired concentration x {( FRC + Circuit volume) +( Cardiac output x B G Coeff.)} DR.Aditi
  • 19.  An alternative method for administering the large amounts of the agents is by directly injecting the agent into the circuit.  This is an old, time-tested method and is extremely reliable. Each ml of the liquid halothane, on vaporisation yields 226 ml of vapour and each ml of liquid isoflurane yields 196 ml of vapour at 20oC.  Hence, the requirement of about 2ml of the agent is injected in small increments into the circuit. The high volatility coupled with the high temperature in the circle results in instantaneous vaporisation of the agent. DR.Aditi
  • 21.  The intermittent injections are often made in 0.2- DR.Aditi 0.5 ml aliquots manually.  Doses should never exceed 1ml at a time. Doses exceeding 2 ml bolus invite disaster.  Intermittent injections can often be easily substituted with a continuous infusion with the added advantage of doing away with the peaks and troughs associated with intermittent injections.
  • 23.  This priming dose is the dose required to bring the circuit volume + FRC to the desired concentration and is injected over the first few minutes of the closed circuit anaesthesia.  Besides this, an amount of agent necessary to compensate for the uptake of the body must also be added and this is calculated depending on the uptake model being used. DR.Aditi
  • 24. 2. Low flow phase DR.Aditi After the high flow phase of 5-15 min, or when the target gas concentrations has been achieved FGF can be reduced at the desired low flow level. The lower the FGF the greater the difference between the vaporizer setting and inspired concentration of the anesthetic agent in the breathing circuit will be. With low FGF, time to reach the desired concentration in the inspiratory gas will be prolonged. Hence, monitoring of oxygen and anesthetic agent concentration is essential and necessary in LFA.
  • 25. ⦁ If the flow provided is too small for the patient’s needs the bellow will gradually go down, down down... DR.Aditi
  • 26. THE MAINTENANCE OF LOW FLOW ANAESTHESIA DR.Aditi ⦁ This phase is characterised by 1.Need for a steady state anaesthesia often meaning a steady alveolar concentration of respiratory gases. 2.Minimal uptake of the anaesthetic agents by the body. 3. Need to prevent hypoxic gas mixtures.
  • 27. ⦁ A high flow of 10 lit/min at the start, for a period of 3 minutes, is followed by a flow of 400 ml of O2 and 600 ml of N2O for the initial 20 minutes. ⦁ And a flow of 500 ml of O2 and 500 ml of N2O thereafter. ⦁ This has been shown to maintain the oxygen concentration between 33 and 40 % at all times. DR.Aditi Management of the oxygen and nitrous oxide flow during the maintenance phase
  • 28. Constant circuit volume : DR.Aditi  Constant reservoir bag size : if the bag decreases in size. The fresh gas flow rate is increased. If the bag increases in size, the flow is decreased.  Ventilator with Ascending bellows: constant volume can be achieved by adjusting the fresh gas flow so that bellows is below the top of its housing at the end of exhalation.  Ventilator with Descending bellows: the fresh gas flow so that bellows just reaches the bottom of its housing at the end of exhalation.
  • 29. Important Equations : DR.Aditi ⦁ VO2 = 10 × BW KG ^ ¾ BRODY EQUATION ⦁ V N20 = 1000 × t ^ ½ EQUATION SEVERINGHAUS ⦁ V AN = desired concentration × λB/G × Q × t − 1/2 LOWE EQUATION
  • 30. ⦁ Time constant : ⦁ The time constant is a measure for the time it takes, that alterations of the fresh gas composition will lead to corresponding alterations of the gas composition within the breathing system. According to a formula given by Conway the time constant (T) can be calculated by the division of the system's volume (VS) by the difference between the amount of anaesthetic agent delivered into the system with the fresh gas (VD) and the individual gas uptake (VU): ⦁ T = VS / (VD - VU) DR.Aditi
  • 31.  The Gothenburg Technique :  Initially high flows, oxygen at 1.5 l/min and nitrous oxide at 3.5 l/min had to be used for a period of six minutes after the induction of anaesthesia and this constitutes the loading phase.  This is followed by the maintenance phase in which the oxygen flow is reduced to about 4ml/kg  And nitrous oxide flow adjusted to maintain a constant oxygen concentration in the circuit.  The usual desired oxygen concentration is about 40%. DR.Aditi
  • 32. Management of the potent anaesthetic agents during maintenance phase DR.Aditi Weir and Kennedy recommend infusion of halothane (in liquid ml/hr) at the following rates for a 50 kg adult at different time intervals. 0-5 min 27 ml/hr 5-30 min 5.71 ml/hr 30-60 min 3.33ml/hr 60-120 min 2.36 ml/hr These infusion rates had been derived from the Lowe's theory of the uptake of anaesthetic agent.
  • 33. They had approximated isoflurane infusion (in liquid ml/hr) based on the Lowe's formula as follows: 0 - 5 min. 14 + 0.4X wt. ml/hr. 5 - 30 min. 0.2 X initial rate. 30-60 min. 0.12Xinitial rate. 60-120min. 0.08X initial rate. For halothane infusion, they had suggested that the above said rates be multiplied by 0.8 And for enflurane, multiplied by 1.6. These rates had been suggested to produce 1.3 MAC without the use of nitrous oxide. The infusion rates had to be halved if nitrous oxide is used. DR.Aditi
  • 34. Category DR.Aditi High flow 5L/Min Inter Mediate 2.5 l/min Low flow 1 l/min Minimal Flow 0.5 l/min Closed circuit 0.3 – 0.5 l/min Percentage 0 % rebreathing 52% 86% 97% 100% Circuit concentratio n with vaporizer set to 1% (at 1 h) 1 % 0.94% 0.68% 0.54% N2O 0.52% NO N2O 0.39 % Vaporizer setting for in inspired concentratio n of 1% ( at 1 h) 1% 1.1% 1.4% 2.0% N2O 2.4% NO N20 3.2%
  • 35. Low flow with Dräger machine : DR.Aditi ⦁ With the connection of the patient to the anaesthesia machine, an initial phase of high fresh gas flow (4-6 L/min) follows. During this initial phase, adequate denitrogenation and distribution of anaesthetic gases in the desired concentration throughout the system is achieved and the desired level of anaesthesia is attained. ⦁ The duration of the initial phase is determined by the amount of flow reduction and the individual gas uptake (4-5 L/min, 6-8 min).
  • 36. ⦁ After this time, oxygen and nitrous oxide levels reach 30% O2 and 65% N2 O, respectively . If isoflurane is used, the vaporizer is set to 1.5%; enflurane and sevoflurane require 2.5% setting and desflurane requires a 4-6% setting. ⦁ After 6-8 min, an expiratory concentration corresponding to 0.8 MAC of the respective anaesthetic agent is attained. At an additive nitrous oxide concentration of 50-60%, this value approximately corresponds to AD95, or agent concentration at which 95% of patients tolerate a skin incision without noticeable reaction. ⦁ After 10 min, the total gas uptake of an adult patient is about 600 ml/min, so that at this time, the flow can be reduced to 1.0 L/min and low flow anaesthesia can be initiated. DR.Aditi
  • 37. ⦁ An inspiratory oxygen concentration level of 30% can only be maintained if the fresh gas oxygen concentration is increased to 50% once the flow has been reduced. ⦁ Flow reduction also decreases the amount of anaesthetic agent, which is introduced into the fresh gas flow by the vaporizer. ⦁ If the initially selected anaesthetic agent concentration of 0.8 × MAC is to be maintained, the vaporizer must be adjusted for 3.0%. ⦁ For desflurane, no changes are necessary. ⦁ Before reducing fresh gas flow rates to even lower levels, i.e., 0.5 L/min, to perform minimal flow anaesthesia, the initial phase should be extended to 15 min and for very large patients to 20 min. DR.Aditi
  • 39. ⦁ Because the rebreathing fraction is increased compared with low flow anaesthesia, oxygen concentration should be increased to 60%; 50% represents an absolute minimum value. ⦁ An expiratory anaesthetic agent concentration of 0.8 × MAC should be maintained with appropriate dial setting. ⦁ In low flow anaesthesia, the composition of anaesthetic gases changes continuously during the course of anaesthesia, making intermittent adjustments to fresh gas composition necessary. DR.Aditi
  • 40. Precautions : DR.Aditi ⦁ If a rapid change in any component of inspired mixture is desired, FGF should be increased. ⦁ If integrity of circle is broken high flows should be used for several minutes before returning to low flow. ⦁ If closed anaesthesia system is used its recommended that high flow be used for 1-2 minutes every hour to eliminate gases such as nitrogen and carbon monoxide.
  • 41. 3. Emergence phase DR.Aditi At the end of anesthesia high FGF, usually 100% O2, is necessary, to facilitate the washout of the anesthetic agent from the patient and to remove the agent to the scavenging system. A charcoal filter can be placed in expiratory limb. It will cause a rapid decrease in volatile agent concentration.
  • 42. There are only two recognised methods of termination of the closed circuit. They are as follows: 1 )Towards the end of the anaesthesia, the circuit is opened and a high flow of gas is used to flush out the anaesthetic agents which accelerates the washout of the anaesthetic agents. This has the obvious advantage of simplicity but would result in wastage of gases. 2 )The second method is the use of activated charcoal. Activated charcoal when heated to 220oC adsorbs the potent vapours almost completely. DR.Aditi
  • 43. Advantage : DR.Aditi  Economic Benefits  Reduce Operating Room Pollution  Environmental Benefits  Estimation Of Anesthetic Agent Uptake And Oxygen Consumption  Buffered Changes In Inspired Conc.  Heat And Humidity Conservation  Less Danger Of Barotrauma  Quality Of Patient Care
  • 44. Disadvantage : DR.Aditi More Attention Required Inability to Quickly Alter Inspired Concentrations Danger of Hypercarbia Accumulation of Undesirable Gases in the System(CO, Methane, Acetone, Hydrogen, Ethanol, Compound A, Argon, Nitrogen) Uncertainty about Inspired Concentrations Faster Absorbent Exhaustion
  • 46. ⦁ Many new anesthesia machines have been developed in Europe within the past few years. One of these is the Physioflex machine . Another is Drager Zeus. ⦁ These machines have an inbuilt algorithm to calculate the uptake and adjust concentration and volume accordingly. DR.Aditi